In yesterday’s Wall Street session, Novo Nordisk ADR (NYSE:NVO) shares traded at $108.97, down -0.21% from the previous session.
NVO stock price is now -2.91% away from the 50-day moving average and -14.42% away from the 200-day moving average. The market capitalization of the company currently stands at $363.79B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $156, Goldman recently initiated with Buy rating for Novo Nordisk ADR (NYSE: NVO). On April 12, 2024, BMO Capital Markets recently initiated its ‘Outperform’ rating on the stock quoting a target price of $163, while ‘Morgan Stanley’ rates the stock as ‘Overweight’
A total of 0.03% of the company’s stock is owned by insiders.
During the past 12 months, Novo Nordisk ADR has had a low of $94.73 and a high of $148.15. As of last week, the company has a debt-to-equity ratio of 0.47, a current ratio of 0.94, and a quick ratio of 0.75. According to the stock market information, the enterprise value for the company is $468282146816, which is based on a 35.34 price-to-earnings ratio, a 3.21 price-to-earnings-growth ratio, and a beta of 0.41. The fifty day moving average price for NVO is $112.5608 and a two-hundred day moving average price translates $127.38985 for the stock.
The latest earnings results from Novo Nordisk ADR (NYSE: NVO) was released for 2024-09-30. The net profit margin was 35.03% and return on equity was 88.20% for NVO. The company reported revenue of $10.51 billion for the quarter, compared to $8.57 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 22.58 percent.
